142 related articles for article (PubMed ID: 10638833)
1. Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts.
Han WR; Murray-Segal LJ; Gershenzon A; Zhang JG; Hodder AN; Pietersz GA; Mottram PL
Transpl Immunol; 1999 Dec; 7(4):207-13. PubMed ID: 10638833
[TBL] [Abstract][Full Text] [Related]
2. Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in mice.
Mottram PL; Han WR; Murray-Segal LJ; Mandel TE; Pietersz GA; McKenzie IF
Transplantation; 1997 Sep; 64(5):684-90. PubMed ID: 9311703
[TBL] [Abstract][Full Text] [Related]
3. Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
Mottram PL; Pietersz GA; Smyth MJ; Purcell LJ; Clunie GJ; McKenzie IF
Transplantation; 1993 Mar; 55(3):484-90. PubMed ID: 8456465
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb.
Hirsch R; Bluestone JA; DeNenno L; Gress RE
Transplantation; 1990 Jun; 49(6):1117-23. PubMed ID: 2141740
[TBL] [Abstract][Full Text] [Related]
5. LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival.
Pietersz GA; Sandrin MS; Ling S; Li YQ; McKenzie IFC
Transpl Immunol; 2001 Oct; 9(1):7-11. PubMed ID: 11680574
[TBL] [Abstract][Full Text] [Related]
6. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients.
Han WR; Murray-Segal LJ; Mottram PL
Transpl Immunol; 1999 Mar; 7(1):37-44. PubMed ID: 10375076
[TBL] [Abstract][Full Text] [Related]
7. Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11).
Henrickson M; Reid J; Bellet JS; Sawchuk SS; Hirsch R
Transplantation; 1995 Oct; 60(8):828-35. PubMed ID: 7482743
[TBL] [Abstract][Full Text] [Related]
8. Idarubicin-anti-CD3 reduces vascular disease in mouse cardiac allografts.
Mottram PL; Han W; Murray-Segal L; Pietersz GA; McKenzie IF
Transplant Proc; 1999; 31(1-2):1414-5. PubMed ID: 10083624
[No Abstract] [Full Text] [Related]
9. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
10. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
11. Treatment of mice with anti-CD3 mAb induces endothelial vascular cell adhesion molecule-1 expression.
Bergese SD; Pelletier RP; Ohye RG; Vallera DA; Orosz CG
Transplantation; 1994 Mar; 57(5):711-7. PubMed ID: 7511256
[TBL] [Abstract][Full Text] [Related]
12. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.
Herold KC; Bluestone JA; Montag AG; Parihar A; Wiegner A; Gress RE; Hirsch R
Diabetes; 1992 Mar; 41(3):385-91. PubMed ID: 1532369
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
[TBL] [Abstract][Full Text] [Related]
14. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
Hirsch R; Archibald J; Gress RE
J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
[TBL] [Abstract][Full Text] [Related]
16. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
[TBL] [Abstract][Full Text] [Related]
17. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
19. Delayed anti-CD3 therapy results in depletion of alloreactive T cells and the dominance of Foxp3+ CD4+ graft infiltrating cells.
Goto R; You S; Zaitsu M; Chatenoud L; Wood KJ
Am J Transplant; 2013 Jul; 13(7):1655-64. PubMed ID: 23750800
[TBL] [Abstract][Full Text] [Related]
20. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
